Quantcast
Last updated on April 17, 2014 at 16:09 EDT

Bacterial Skin and Skin Structure Infections Market: SSSI Pipeline Review, H2 2013 at ReportsnReports.com

January 10, 2014

Skin and Skin Structure Infections (SSSI) Caused By Bacteria – Pipeline Review, H2 2013 report provides review on products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Dallas, Texas (PRWEB) January 10, 2014

Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria. Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Pipeline Review (http://www.reportsnreports.com/reports/271749-skin-and-skin-structure-infections-sssi-caused-by-bacteria-pipeline-review-h2-2013.html), Half Year is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Scope

  • A snapshot of the global therapeutic scenario for Skin And Skin Structure Infections (SSSI) Caused By Bacteria.
  • A review of the Skin And Skin Structure Infections (SSSI) Caused By Bacteria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Skin And Skin Structure Infections (SSSI) Caused By Bacteria pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=271749.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Skin And Skin Structure Infections (SSSI) Caused By Bacteria pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=271749.

List of Tables

Number of Products Under Development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria, H2 2013

Products under Development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Comparative Analysis, H2 2013

Number of Products under Development by Companies, H2 2013

Comparative Analysis by Late Stage Development, H2 2013

Comparative Analysis by Mid Clinical Stage Development, H2 2013

Comparative Analysis by Early Clinical Stage Development, H2 2013

Comparative Analysis by Pre-Clinical Stage Development, H2 2013

Products under Development by Companies, H2 2013

GlaxoSmithKline plc, H2 2013

Cubist Pharmaceuticals, Inc., H2 2013

Paratek Pharmaceuticals, Inc., H2 2013

Affinium Pharmaceuticals, Inc., H2 2013

MerLion Pharmaceuticals Pte Ltd, H2 2013

Nabriva Therapeutics AG, H2 2013

Cempra Pharmaceuticals, Inc., H2 2013

Tetraphase Pharmaceuticals Inc., H2 2013

Durata Therapeutics Inc., H2 2013

Assessment by Monotherapy Products, H2 2013

Assessment by Stage and Route of Administration, H2 2013

Assessment by Stage and Molecule Type, H2 2013

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Therapeutics – Drug Profile Updates

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Therapeutics – Dormant Products

List of Figures

Number of Products under Development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria, H2 2013

Products under Development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Comparative Analysis, H2 2013

Products under Development by Companies, H2 2013

Late Stage Products, H2 2013

Mid Clinical Stage Products, H2 2013

Early Clinical Stage Products, H2 2013

Pre-Clinical Stage Products, H2 2013

Assessment by Monotherapy Products, H2 2013

Assessment by Route of Administration, H2 2013

Assessment by Stage and Route of Administration, H2 2013

Assessment by Molecule Type, H2 2013

Assessment by Stage and Molecule Type, H2 2013

Explore more reports from Global Markets Direct Market @ http://www.reportsnreports.com/publisher/global-markets-direct/ and Skincare Market.

About Us

ReportsnReports.com is an online market research reports (http://www.reportsnreports.com/) library of 200,000+ reports and in-depth studies of 5000+ micro markets.

For the original version on PRWeb visit: http://www.prweb.com/releases/bacterial-skin-and-skin/structure-infections-sssi/prweb11478629.htm


Source: prweb